Article

Direct binding of arsenicals to nuclear transport factors disrupts nucleocytoplasmic…

medRxiv · 2025 · Lorentzon, E.; Lee, J.; Masaryk, J.; Keuenhof, K.; Karlsson, N.; Galipaud, C.; Madsen, R.; Hoog, J. L.; Levin, D. E.; Tamas, M. J.

Key facts

Title Direct binding of arsenicals to nuclear transport factors disrupts nucleocytoplasmic transport
First author Lorentzon, E.; Lee, J.; Masaryk, J.; Keuenhof, K.; Karlsson, N.; Galipaud, C.; Madsen, R.; Hoog, J. L.; Levin, D. E.; Tamas, M. J.
Journal medRxiv
Published Jan 1, 2025
DOI 10.1101/2025.01.13.632748
Devices mentioned K800552, K810863, K853723, K860811, K862004, K874160, K874609, K912581, K915561, K915840, K920529, K920967 and 12 more
Product codes mentioned CEK, DBM, DEW, MTX, CFN, EPT, GCJ, GCT, GEX, HET, HJO, HLI and 3 more

At a glance

  • 10–99 FDA submissions mentioned
  • 10–99 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature